Subjects: Therapeutic Equivalency / Titles: Compliance policy for the quantity of bioavailability and bioequivalence samples retained under 21 CFR 320.38(c) - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Therapeutic Equivalency ✖ Titles Compliance policy for the quantity of bioavailability and bioequivalence samples retained under 21 CFR 320.38(c) ✖

1. Compliance policy for the quantity of bioavailability and bioequivalence samples retained under 21 CFR 320.38(c)

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, August 2020
Subject(s):: Biological Availability
Therapeutic Equivalency
Biopharmaceutics
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.